Procurement Summary
Country : United Kingdom
Summary : Continuous Positive Airway Pressure (Cpap) Service
Deadline : 13 Jun 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 119143315
Document Ref. No. :
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : GBP 11306000
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Obstructive Sleep Apnoea (OSA) is a prevalent sleep-related respiratory disorder characterised by recurrent upper airway obstruction during sleep, resulting in intermittent pauses in breathing. This leads to fragmented sleep, excessive daytime sleepiness, and significantly increases the risk of developing serious comorbidities such as hypertension, diabetes, cardiovascular disease, and stroke. OSA affects approximately 5% of the population, with a substantial proportion remaining undiagnosed. The condition is particularly burdensome in individuals with coexisting chronic obstructive pulmonary disease (COPD) or obesity hypoventilation syndrome (OSAHS), where symptoms and health risks are further exacerbated. Continuous Positive Airway Pressure (CPAP) therapy is the first-line treatment for OSA, delivering a constant flow of air via a mask to maintain airway patency during sleep. Effective management requires consistent nightly use. CPAP devices typically have a lifespan of 7 years, while masks are single-patient use items requiring replacement every 6 to 12 months and regular patient cleaning to ensure optimal function and hygiene. At Gloucestershire Hospitals NHS Foundation Trust (GHNHSFT), there are currently around 5, 500 patients utilising CPAP therapy and a further 300 patients using other forms of non-invasive ventilation. This generates an annual requirement for approximately 6, 000 masks and tubes, and 1, 200 filters. The service manages roughly 950 patient contacts per m...
Documents
Tender Notice